Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131880) titled 'Comparison of the efficacy and safety of Eravacycline and Sulbactam combined with polymyxin in the treatment of CRAB pneumonia' on Sept. 7.

Study Type: Observational study

Study Design: Case-Control study

Primary Sponsor: The Affiliated Hospital of Xuzhou Medical University

Condition: Carbapenem-Resistant Acinetobacter baumannii Pneumonia

Intervention: eravacycline combined with polymyxin group:None

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-09-10

Target Sample Size: eravacycline combined with polymyxin group:30;Sultamicillin Combined with Polymyxin Group:50;

Cou...